Functional assays to screen and select monoclonal antibodies that target <i>Yersinia pestis</i>.

Hum Vaccin Immunother · 2023 · PMC10332183 · PMID 37289480

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Treatment with F1–04-A-G1 and 4F12 afforded 75% survival, although the MTD was greater following F1–04-A-G1 treatment (18.6 days vs 8.6 days), but the MTD difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.